---
document_datetime: 2025-11-23 08:00:55
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/extavia.html
document_name: extavia.html
version: success
processing_time: 0.1063972
conversion_datetime: 2025-12-28 13:15:46.135662
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Extavia

[RSS](/en/individual-human-medicine.xml/66760)

##### Withdrawn

This medicine's authorisation has been withdrawn

interferon beta-1b

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 25 November 2024, the European Commission withdrew the marketing authorisation for Extavia (interferon beta-1B) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Novartis Europharm Limited, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Extavia was granted marketing authorisation in the EU on 20 May 2008 for the treatment of single demyelinating events with an active inflammatory process and multiple sclerosis. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2012.

Extavia is identical to Betaferon which is authorised in the EU with the same indication as Extavia.

Extavia : EPAR - Summary for the public

Reference Number: EMA/307167/2012

English (EN) (228.41 KB - PDF)

**First published:** 05/06/2008

**Last updated:** 30/04/2025

[View](/en/documents/overview/extavia-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-317)

български (BG) (292.32 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/bg/documents/overview/extavia-epar-summary-public_bg.pdf)

español (ES) (229.52 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/es/documents/overview/extavia-epar-summary-public_es.pdf)

čeština (CS) (273.9 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/cs/documents/overview/extavia-epar-summary-public_cs.pdf)

dansk (DA) (227.64 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/da/documents/overview/extavia-epar-summary-public_da.pdf)

Deutsch (DE) (234.81 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/de/documents/overview/extavia-epar-summary-public_de.pdf)

eesti keel (ET) (211.75 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/et/documents/overview/extavia-epar-summary-public_et.pdf)

ελληνικά (EL) (306.59 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/el/documents/overview/extavia-epar-summary-public_el.pdf)

français (FR) (233.96 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/fr/documents/overview/extavia-epar-summary-public_fr.pdf)

hrvatski (HR) (262.41 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/hr/documents/overview/extavia-epar-summary-public_hr.pdf)

italiano (IT) (229.79 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/it/documents/overview/extavia-epar-summary-public_it.pdf)

latviešu valoda (LV) (285.41 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/lv/documents/overview/extavia-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (267.43 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/lt/documents/overview/extavia-epar-summary-public_lt.pdf)

magyar (HU) (259.4 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/hu/documents/overview/extavia-epar-summary-public_hu.pdf)

Malti (MT) (278.04 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/mt/documents/overview/extavia-epar-summary-public_mt.pdf)

Nederlands (NL) (229.18 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/nl/documents/overview/extavia-epar-summary-public_nl.pdf)

polski (PL) (272.45 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/pl/documents/overview/extavia-epar-summary-public_pl.pdf)

português (PT) (231.85 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/pt/documents/overview/extavia-epar-summary-public_pt.pdf)

română (RO) (273.35 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/ro/documents/overview/extavia-epar-summary-public_ro.pdf)

slovenčina (SK) (267.91 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/sk/documents/overview/extavia-epar-summary-public_sk.pdf)

slovenščina (SL) (263.8 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/sl/documents/overview/extavia-epar-summary-public_sl.pdf)

Suomi (FI) (225.06 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/fi/documents/overview/extavia-epar-summary-public_fi.pdf)

svenska (SV) (224.34 KB - PDF)

**First published:**

05/06/2008

**Last updated:**

30/04/2025

[View](/sv/documents/overview/extavia-epar-summary-public_sv.pdf)

Extavia : EPAR - Risk-management-plan summary

English (EN) (657.41 KB - PDF)

**First published:** 17/10/2019

**Last updated:** 30/04/2025

[View](/en/documents/rmp-summary/extavia-epar-risk-management-plan-summary_en.pdf)

## Product information

Extavia : EPAR - Product Information

English (EN) (2.51 MB - PDF)

**First published:** 07/12/2009

**Last updated:** 30/04/2025

[View](/en/documents/product-information/extavia-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-187)

български (BG) (3.1 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/bg/documents/product-information/extavia-epar-product-information_bg.pdf)

español (ES) (2.51 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/es/documents/product-information/extavia-epar-product-information_es.pdf)

čeština (CS) (2.89 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/cs/documents/product-information/extavia-epar-product-information_cs.pdf)

dansk (DA) (2.56 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/da/documents/product-information/extavia-epar-product-information_da.pdf)

Deutsch (DE) (2.82 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/de/documents/product-information/extavia-epar-product-information_de.pdf)

eesti keel (ET) (2.59 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/et/documents/product-information/extavia-epar-product-information_et.pdf)

ελληνικά (EL) (3.41 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/el/documents/product-information/extavia-epar-product-information_el.pdf)

français (FR) (2.96 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/fr/documents/product-information/extavia-epar-product-information_fr.pdf)

hrvatski (HR) (2.95 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/hr/documents/product-information/extavia-epar-product-information_hr.pdf)

íslenska (IS) (2.51 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/is/documents/product-information/extavia-epar-product-information_is.pdf)

italiano (IT) (2.64 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/it/documents/product-information/extavia-epar-product-information_it.pdf)

latviešu valoda (LV) (2.85 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/lv/documents/product-information/extavia-epar-product-information_lv.pdf)

lietuvių kalba (LT) (2.9 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/lt/documents/product-information/extavia-epar-product-information_lt.pdf)

magyar (HU) (2.89 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/hu/documents/product-information/extavia-epar-product-information_hu.pdf)

Malti (MT) (3.46 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/mt/documents/product-information/extavia-epar-product-information_mt.pdf)

Nederlands (NL) (2.55 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/nl/documents/product-information/extavia-epar-product-information_nl.pdf)

norsk (NO) (2.58 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/no/documents/product-information/extavia-epar-product-information_no.pdf)

polski (PL) (2.88 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/pl/documents/product-information/extavia-epar-product-information_pl.pdf)

português (PT) (2.61 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/pt/documents/product-information/extavia-epar-product-information_pt.pdf)

română (RO) (2.67 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/ro/documents/product-information/extavia-epar-product-information_ro.pdf)

slovenčina (SK) (2.88 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/sk/documents/product-information/extavia-epar-product-information_sk.pdf)

slovenščina (SL) (2.75 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/sl/documents/product-information/extavia-epar-product-information_sl.pdf)

Suomi (FI) (2.62 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/fi/documents/product-information/extavia-epar-product-information_fi.pdf)

svenska (SV) (2.47 MB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/sv/documents/product-information/extavia-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** II/0116/G 08/12/2022

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Extavia : EPAR - All Authorised presentations

English (EN) (210.06 KB - PDF)

**First published:** 07/12/2009

**Last updated:** 30/04/2025

[View](/en/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-606)

български (BG) (192.81 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/bg/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_bg.pdf)

español (ES) (215.1 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/es/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_es.pdf)

čeština (CS) (229.01 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/cs/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (169.94 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/da/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (178.47 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/de/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (177.6 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/et/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (247.46 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/el/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_el.pdf)

français (FR) (184.89 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/fr/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (219.37 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/hr/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (172.35 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/is/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_is.pdf)

italiano (IT) (210.06 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/it/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (182.29 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/lv/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (182.42 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/lt/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (178.94 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/hu/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (195.53 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/mt/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (221.82 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/nl/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (166.49 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/no/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_no.pdf)

polski (PL) (175.55 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/pl/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_pl.pdf)

português (PT) (170.27 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/pt/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_pt.pdf)

română (RO) (221.28 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/ro/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (192.26 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/sk/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (221.05 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/sl/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (181.49 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/fi/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (169.55 KB - PDF)

**First published:**

07/12/2009

**Last updated:**

30/04/2025

[View](/sv/documents/all-authorised-presentations/extavia-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Extavia Active substance interferon beta-1b International non-proprietary name (INN) or common name interferon beta-1b Therapeutic area (MeSH) Multiple Sclerosis Anatomical therapeutic chemical (ATC) code L03AB08

### Pharmacotherapeutic group

Immunostimulants

### Therapeutic indication

Extavia is indicated for the treatment of:

- patients with a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis;
- patients with relapsing-remitting multiple sclerosis and two or more relapses within the last two years;
- patients with secondary progressive multiple sclerosis with active disease, evidenced by relapses.

## Authorisation details

EMA product number EMEA/H/C/000933 Marketing authorisation holder

Novartis Europharm Limited

Vista Building

Opinion adopted 19/03/2008 Marketing authorisation issued 20/05/2008 Withdrawal of marketing authorisation 25/04/2025 Revision 26

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Extavia : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (1.21 MB - PDF)

**First published:** 07/12/2009

**Last updated:** 30/04/2025

[View](/en/documents/procedural-steps-after/extavia-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Extavia : EPAR - Public assessment report

English (EN) (105.83 KB - PDF)

**First published:** 05/06/2008

**Last updated:** 30/04/2025

[View](/en/documents/assessment-report/extavia-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Extavia

Reference Number: EMEA/CHMP/138637/2008

English (EN) (64.11 KB - PDF)

**First published:** 20/03/2008

**Last updated:** 30/04/2025

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-extavia_en.pdf)

**This page was last updated on** 30/04/2025

## Share this page

[Back to top](#main-content)